Yes: the flu-iiQ™ is suitable for COVID-19 clinical trials

We have recently received several enquiries about the potential of the flu-iiQ™ (including recent extensions to other respiratory infections) for use in COVID-19 clinical trials. We confirm that the flu-iiQ™ covers all the key symptoms and is ready for deployment in 50+ languages.